Merten Jesse E 4
4 · ALLSTATE CORP · Filed Feb 26, 2026
Research Summary
AI-generated summary of this filing
Allstate (ALL) Pres Jesse Merten Exercises Options and Sells Shares
What Happened
- Jesse E. Merten, President – Personal Property & Liability at Allstate, exercised/conversion transactions and sold shares. On Feb 24–25, 2026 he acquired 35,187 shares (12,879 @ $122.64; 1,734 @ $133.00; 19,373 @ $137.10; plus 1,201 RSU shares converted at $0.00) and disposed of 34,519 shares (open‑market sales plus 533 shares withheld to cover tax) for aggregate proceeds of $7,200,319. The exercises generated ~$4.47M in intrinsic value based on exercise prices; most of the newly acquired shares were sold the next day under a prearranged plan.
Key Details
- Transaction dates: Feb 24–25, 2026; Form 4 filed Feb 26, 2026.
- Acquired: 35,187 shares (includes RSU conversion of 1,201 shares at $0.00).
- Disposed: 34,519 shares (open‑market sales: 8,811; 15,893; 7,982; 1,300; plus 533 shares for tax withholding).
- Proceeds from sales: $7,200,319 (sales and tax withholding combined).
- Net result: +668 shares retained (35,187 acquired − 34,519 disposed).
- Notable footnotes:
- RSU conversion (F1): 1,201 RSUs converted to shares at $0; remaining RSUs vest in 2027 and 2028.
- 10b5‑1 plan (F2): The option exercise and sale transactions were executed pursuant to a Rule 10b5‑1 trading plan adopted Nov 7, 2025.
- Weighted average sale price disclosures (F3–F6): sale groups had narrow price ranges (approx. $206.96–$210.47); reporter can provide per‑share price breakdown on request.
- Codes explained: M = option exercise/conversion, S = sale, F = tax withholding/payment.
- Timeliness: Form 4 was filed Feb 26 for transactions on Feb 24–25; no late filing flag indicated.
Context
- This was effectively a cashless exercise + immediate disposition pattern: options/RSUs were converted/exercised and the majority of resulting shares were sold the following day under a prearranged 10b5‑1 plan. For retail investors, exercises followed by immediate sales are commonly routine (to cover exercise costs/taxes or to diversify) and do not necessarily signal a change in the insider’s view of the company.
Insider Transaction Report
Form 4
Merten Jesse E
Other
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-02-24+1,201→ 32,834 total - Tax Payment
Common Stock
2026-02-24$209.82/sh−533$111,834→ 32,301 total - Exercise/Conversion
Common Stock
[F2]2026-02-25$122.64/sh+12,879$1,579,481→ 45,180 total - Exercise/Conversion
Common Stock
[F2]2026-02-25$133.00/sh+1,734$230,622→ 46,914 total - Exercise/Conversion
Common Stock
[F2]2026-02-25$137.10/sh+19,373$2,656,038→ 66,287 total - Sale
Common Stock
[F2][F3]2026-02-25$207.53/sh−8,811$1,828,559→ 57,476 total - Sale
Common Stock
[F2][F4]2026-02-25$208.58/sh−15,893$3,314,887→ 41,583 total - Sale
Common Stock
[F2][F5]2026-02-25$209.40/sh−7,982$1,671,469→ 33,601 total - Sale
Common Stock
[F2][F6]2026-02-25$210.44/sh−1,300$273,570→ 32,301 total - Exercise/Conversion
Restricted Stock Units
[F1]2026-02-24−1,201→ 2,402 totalExp: 2028-02-24→ Common Stock (1,201 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F2]2026-02-25−12,879→ 0 totalExercise: $122.64From: 2025-02-17Exp: 2032-02-17→ Common Stock (12,879 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F2]2026-02-25−1,734→ 868 totalExercise: $133.00From: 2025-10-05Exp: 2032-10-05→ Common Stock (1,734 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F2]2026-02-25−19,373→ 9,687 totalExercise: $137.10From: 2026-02-16Exp: 2033-02-16→ Common Stock (19,373 underlying)
Holdings
- 7,823(indirect: By 401(k))
Common Stock
Footnotes (6)
- [F1]Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on February 24, 2027 and February 24, 2028.
- [F2]The option exercise and sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on November 7, 2025.
- [F3]Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $206.96 to $207.86. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
- [F4]Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $207.96 to $208.95. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
- [F5]Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $208.97 to $209.96. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
- [F6]Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $210.06 to $210.47. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
Signature
/s/ Meghan E. Jauhar, attorney-in-fact for Jesse E. Merten|2026-02-26